NIAID – program announcements for planning or implementation of clinical trials

May 23, 2016 by School of Medicine Webmaster

NIAID Clinical Trial Implementation Grant (R01)
(PAR-16-269)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NIAID Clinical Trial Implementation Cooperative Agreement (U01)
(PAR-16-270)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)
(PAR-16-271)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization.

NIAID Clinical Trial Planning Grant (R34)
(PAR-16-272)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Filed Under: Funding Opportunities